MYLAN 6727 MYLAN 6727
Pill imprint MYLAN 6727 MYLAN 6727 has been identified as Zonisamide 100 mg.
Zonisamide is used in the treatment of seizures; migraine prevention; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy.
Zonisamide 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Zonisamide Images
- Imprint:
-
MYLAN 6727
MYLAN 6727 - Strength:
- 100 mg
- Color:
- Purple / Blue
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
microcrystalline cellulose
propylene glycol
shellac
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 3
gelatin
magnesium stearate
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6727
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0768 | UDL Laboratories Inc |
| 16590-0539 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Zonisamide resources
- Zonisamide (Wolters Kluwer)
- zonisamide (Cerner Multum)
- zonisamide (Micromedex) - Includes Dosage Information
- Zonisamide (AHFS DI)
- Zonisamide Capsules (FDA)
- Zonisamide (Wolters Kluwer)
Search Again
